Search results - ORA - Oxford University Research Archive

1 - 10 of 10

1

Journal article

Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017

Lozano, R, Fullman, N, Abate, D, et al.
2018-11-08

2

Journal article

Control of blood pressure and low-density lipoprotein cholesterol with single-pill amlodipine/atorvastatin: a pooled analysis of patients with and without diabetes

Jenssen, T, Aguilar-Salinas, C, Hobbs, R, et al.
2008-09-01

3

Journal article

The minimum information about a genome sequence (MIGS) specification.

Field, D, Garrity, G, Gray, T, et al.
2008-05-01

4

Conference item

A Comparison of Blood Pressure and Low-Density Lipoprotein Cholesterol Reduction After Treatment With Single-Pill Amlodipine/Atorvastatin In Elderly (75 years or more) and Younger (less than 75 years) Patients: Results of a Posted Analysis of 5559 Patients

Feldman, R, Flack, J, Hobbs, R, et al.
2009-11-01

5

Journal article

International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme.

Richard Hobbs, F, Gensini, G, John Mancini, G, et al.
2009-08-01

6

Journal article

Impact of age and gender on blood pressure and low-density lipoprotein cholesterol reduction: results of a pooled analysis.

Feldman, R, Flack, J, Howes, L, et al.
2012-09-01

7

Conference item

A Comparison of Blood Pressure and Low-Density Lipoprotein Cholesterol Reduction After Treatment With Single-Pill Amlodipine/Atorvastatin in Younger (Less Than 65 Years) and Older (65 Years or More) Men and Women Results of a Pooled Analysis of 5559 Patients

Hobbs, R, Feldman, R, Flack, J, et al.
2009-11-01

8

Journal article

Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program).

Hobbs, F, Gensini, G, Mancini, G, et al.
2006-06-01

9

Conference item

Utility of amlodipine/atorvastatin single-pill therapy in patients with diabetes mellitus or metabolic syndrome: Results from the JEWEL programme

Hobbs, R, Gensini, G, Mancini, G, et al.
2006-09-01

10

Conference item

Reduction in Blood Pressure and Low-Density Lipoprotein Cholesterol When Single-Pill Amlodipine/Atorvastatin is Used as First-Line or Add-On Treatment

Flack, J, Feldman, R, Hobbs, R, et al.
2009-11-01

TO TOP